Mirtazapine Tablet, Film Coated
Product Images NDC 17856-0101

2 FDA label images from Atlantic Biologicals Corp. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 17856-0101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

Mirtazpine Structure (Mirtazapine Str)
Chemical structure of Mirtazapine, a compound consisting of interconnected aromatic rings and a methylated nitrogen atom, as depicted in the image.*
FDA Label Image

1 (17856 0101 01 Case Label)

1 (17856 0101 01 Case Label)
Label for Mirtazapine 7.5 mg film-coated tablets by Atlantic Biologicals Corp. The label indicates the product is an oral human prescription drug, with 7.5 mg per tablet strength, packaged with a quantity of 100 tablets. Storage instructions recommend 25°C with allowed excursions, and a call to reorder phone number is provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.